Cite

HARVARD Citation

    Bordi, P. et al. (2014). Overcoming T790M-driven Acquired Resistance to EGFR-TKIs in NSCLC with Afatinib: A Case Report. Tumori. 100 (1), pp. e20-e23. [Online]. 
  
Back to record